RU2008132144A - APPLICATION OF THE UNSAPTIBLE EXTRACT OF VEGETABLE PULP FOR TREATMENT OF AGING OF SKIN - Google Patents

APPLICATION OF THE UNSAPTIBLE EXTRACT OF VEGETABLE PULP FOR TREATMENT OF AGING OF SKIN Download PDF

Info

Publication number
RU2008132144A
RU2008132144A RU2008132144/15A RU2008132144A RU2008132144A RU 2008132144 A RU2008132144 A RU 2008132144A RU 2008132144/15 A RU2008132144/15 A RU 2008132144/15A RU 2008132144 A RU2008132144 A RU 2008132144A RU 2008132144 A RU2008132144 A RU 2008132144A
Authority
RU
Russia
Prior art keywords
use according
extract
skin
skin disorders
amyrin
Prior art date
Application number
RU2008132144/15A
Other languages
Russian (ru)
Other versions
RU2428170C2 (en
Inventor
Бернар ФАБР (FR)
Бернар ФАБР
Рене БЕЛЬ (FR)
Рене Бель
Мари ШАРВЕРОН (FR)
Мари Шарверон
Каролин БОДУЭН (FR)
Каролин БОДУЭН
Original Assignee
Пьер Фабр Дермо-Косметик (Fr)
Пьер Фабр Дермо-Косметик
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пьер Фабр Дермо-Косметик (Fr), Пьер Фабр Дермо-Косметик filed Critical Пьер Фабр Дермо-Косметик (Fr)
Publication of RU2008132144A publication Critical patent/RU2008132144A/en
Application granted granted Critical
Publication of RU2428170C2 publication Critical patent/RU2428170C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Применение неомыляемого экстракта растительной пульпы, содержащего тритерпеновую фракцию, отличающееся тем, что указанная тритерпеновая фракция содержит эритродиол, α-амирин, β-амирин и лупеол, для получения косметического, фармацевтического или пищевого продукта, предназначенного для профилактики и/или лечения нарушений кожи, связанных со старением кожи, при этом содержание эритродиола составляет от 7 до 40 вес.% неомыляемого экстракта. ! 2. Применение по п.1, отличающееся тем, что массовая фракция β-амирина составляет от 5% до 30% неомыляемого экстракта. ! 3. Применение по п.1, отличающееся тем, что сумма массовых фракций α-амирина и лупеола составляет от 10% до 50% неомыляемого экстракта. ! 4. Применение по п.1, отличающееся тем, что количество указанного экстракта в конечном косметическом продукте составляет от 0,001% до 50%, предпочтительно от 0,01% до 10% и более предпочтительно от 0,1 до 2 вес.% от общего веса препарата. ! 5. Применение по п.1, отличающееся тем, что указанный экстракт получают из растения, выбранного из семейства растений Sapotaceae. ! 6. Применение по п.1, отличающееся тем, что указанный экстракт получают из пульпы плодов аргании. ! 7. Применение по п.1, отличающееся тем, что кожные нарушения проявляются в виде изменений текстуры, цвета, прозрачности кожи и появления морщин. ! 8. Применение по п.1, отличающееся тем, что кожные нарушения являются следствием снижения или отсутствия ответа на внешний стресс. ! 9. Применение по п.8, отличающееся тем, что внешний стресс вызван солнцем, табаком. ! 10. Применение по п.1, отличающееся тем, что кожные нарушения являются следствием снижения или отсутствия индуцирования белков HSP72. ! 11. Применен�1. The use of unsaponifiable extract of plant pulp containing a triterpene fraction, characterized in that said triterpene fraction contains erythrodiol, α-amyrin, β-amyrin and lupeol, to obtain a cosmetic, pharmaceutical or food product intended for the prevention and / or treatment of skin disorders associated with skin aging, while the content of erythrodiol is from 7 to 40 wt.% unsaponifiable extract. ! 2. The use according to claim 1, characterized in that the mass fraction of β-amirin is from 5% to 30% unsaponifiable extract. ! 3. The use according to claim 1, characterized in that the sum of the mass fractions of α-amyrin and lupeol is from 10% to 50% unsaponifiable extract. ! 4. The use according to claim 1, characterized in that the amount of said extract in the final cosmetic product is from 0.001% to 50%, preferably from 0.01% to 10% and more preferably from 0.1 to 2 wt.% Of the total the weight of the drug. ! 5. The use according to claim 1, characterized in that said extract is obtained from a plant selected from the Sapotaceae plant family. ! 6. The use according to claim 1, characterized in that said extract is obtained from pulp of argan fruit. ! 7. The use according to claim 1, characterized in that skin disorders occur in the form of changes in texture, color, transparency of the skin and the appearance of wrinkles. ! 8. The use according to claim 1, characterized in that skin disorders are the result of a decrease or lack of response to external stress. ! 9. The use of claim 8, characterized in that the external stress is caused by the sun, tobacco. ! 10. The use according to claim 1, characterized in that skin disorders are the result of a decrease or absence of induction of HSP72 proteins. ! 11. Applied

Claims (13)

1. Применение неомыляемого экстракта растительной пульпы, содержащего тритерпеновую фракцию, отличающееся тем, что указанная тритерпеновая фракция содержит эритродиол, α-амирин, β-амирин и лупеол, для получения косметического, фармацевтического или пищевого продукта, предназначенного для профилактики и/или лечения нарушений кожи, связанных со старением кожи, при этом содержание эритродиола составляет от 7 до 40 вес.% неомыляемого экстракта.1. The use of unsaponifiable extract of plant pulp containing a triterpene fraction, characterized in that said triterpene fraction contains erythrodiol, α-amyrin, β-amyrin and lupeol, to obtain a cosmetic, pharmaceutical or food product intended for the prevention and / or treatment of skin disorders associated with skin aging, while the content of erythrodiol is from 7 to 40 wt.% unsaponifiable extract. 2. Применение по п.1, отличающееся тем, что массовая фракция β-амирина составляет от 5% до 30% неомыляемого экстракта.2. The use according to claim 1, characterized in that the mass fraction of β-amirin is from 5% to 30% unsaponifiable extract. 3. Применение по п.1, отличающееся тем, что сумма массовых фракций α-амирина и лупеола составляет от 10% до 50% неомыляемого экстракта.3. The use according to claim 1, characterized in that the sum of the mass fractions of α-amyrin and lupeol is from 10% to 50% unsaponifiable extract. 4. Применение по п.1, отличающееся тем, что количество указанного экстракта в конечном косметическом продукте составляет от 0,001% до 50%, предпочтительно от 0,01% до 10% и более предпочтительно от 0,1 до 2 вес.% от общего веса препарата.4. The use according to claim 1, characterized in that the amount of said extract in the final cosmetic product is from 0.001% to 50%, preferably from 0.01% to 10% and more preferably from 0.1 to 2 wt.% Of the total the weight of the drug. 5. Применение по п.1, отличающееся тем, что указанный экстракт получают из растения, выбранного из семейства растений Sapotaceae.5. The use according to claim 1, characterized in that said extract is obtained from a plant selected from the Sapotaceae plant family. 6. Применение по п.1, отличающееся тем, что указанный экстракт получают из пульпы плодов аргании.6. The use according to claim 1, characterized in that said extract is obtained from pulp of argan fruit. 7. Применение по п.1, отличающееся тем, что кожные нарушения проявляются в виде изменений текстуры, цвета, прозрачности кожи и появления морщин.7. The use according to claim 1, characterized in that skin disorders are manifested in the form of changes in texture, color, transparency of the skin and the appearance of wrinkles. 8. Применение по п.1, отличающееся тем, что кожные нарушения являются следствием снижения или отсутствия ответа на внешний стресс.8. The use according to claim 1, characterized in that skin disorders are the result of a decrease or lack of response to external stress. 9. Применение по п.8, отличающееся тем, что внешний стресс вызван солнцем, табаком.9. The use of claim 8, characterized in that the external stress is caused by the sun, tobacco. 10. Применение по п.1, отличающееся тем, что кожные нарушения являются следствием снижения или отсутствия индуцирования белков HSP72.10. The use according to claim 1, characterized in that the skin disorders are the result of a decrease or lack of induction of HSP72 proteins. 11. Применение по п.1, отличающееся тем, что косметический, фармацевтический или пищевой продукт имеет форму для перорального введения или топического нанесения, предпочтительно форму для топического нанесения.11. The use according to claim 1, characterized in that the cosmetic, pharmaceutical or food product has a form for oral administration or topical application, preferably a form for topical application. 12. Применение по п.1, отличающееся тем, что форму для топического нанесения выбирают из группы, включающей кремы, гели, мази и спреи.12. The use according to claim 1, characterized in that the form for topical application is selected from the group comprising creams, gels, ointments and sprays. 13. Применение по п.1, отличающееся тем, что форму для перорального введения выбирают из группы, включающей таблетки, желатиновые капсулы и порошки для питьевых суспензий. 13. The use according to claim 1, characterized in that the form for oral administration is selected from the group comprising tablets, gelatin capsules and powders for drinking suspensions.
RU2008132144/15A 2006-01-05 2006-12-28 Application of nonsaponifying extract of vegetable pulp for treatment of skin aging RU2428170C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0600077A FR2895677B1 (en) 2006-01-05 2006-01-05 USE OF AN INSAPONIFIABLE VEGETABLE PULP EXTRACT IN THE TREATMENT OF SKIN AGING.
FR0600077 2006-01-05

Publications (2)

Publication Number Publication Date
RU2008132144A true RU2008132144A (en) 2010-02-10
RU2428170C2 RU2428170C2 (en) 2011-09-10

Family

ID=36991296

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008132144/15A RU2428170C2 (en) 2006-01-05 2006-12-28 Application of nonsaponifying extract of vegetable pulp for treatment of skin aging

Country Status (19)

Country Link
US (1) US20090012049A1 (en)
EP (1) EP1968536A2 (en)
JP (1) JP2009522341A (en)
KR (1) KR20080083134A (en)
CN (1) CN101355926B (en)
AU (1) AU2006336002A1 (en)
BR (1) BRPI0620949A2 (en)
CA (1) CA2636114A1 (en)
FR (1) FR2895677B1 (en)
HK (1) HK1124779A1 (en)
IL (1) IL192428A0 (en)
MA (1) MA30035B1 (en)
NO (1) NO20083307L (en)
NZ (1) NZ569203A (en)
RU (1) RU2428170C2 (en)
TN (1) TNSN08290A1 (en)
UA (1) UA95790C2 (en)
WO (1) WO2007083006A2 (en)
ZA (1) ZA200805112B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2958163B1 (en) 2010-03-31 2014-06-13 Fabre Pierre Dermo Cosmetique PREPARATION FROM IN VITRO CULTURE OF NON-ELICITED ARGANIER DIFFERENTIAL CELLS, USE THEREOF FOR THE TREATMENT OF SKIN AGING, INFLAMMATION AND HEALING, AND OBTAINING THEM.
US10646430B2 (en) 2014-04-30 2020-05-12 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
BR112016023890B1 (en) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc methods to reduce signs of skin aging, to increase adipogenesis of the face and body and to increase lipogenesis of the face and body
AU2014392682B2 (en) 2014-04-30 2020-07-09 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of skin aging using a combination of extracts
MX2016013198A (en) 2014-04-30 2017-01-16 Kimberly Clark Co Use of undaria extract to reduce signs of skin aging.
WO2015167539A2 (en) * 2014-04-30 2015-11-05 Kimberly-Clark Worldwide, Inc. Topical composition including a combination of extracts for reducing signs of skin aging
AU2014392689B2 (en) 2014-04-30 2020-12-17 Kimberly-Clark Worldwide, Inc. Compositions and methods for reducing oxidative stress
JP2023162457A (en) * 2020-09-09 2023-11-09 株式会社Adeka Method for producing argan extract, argan extract, hair growth promoter, hair loss prevention agent, and hair cycle regulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702773B1 (en) * 1993-03-19 1995-06-16 Deslog PROCESS FOR THE PREPARATION OF FRACTIONS OF FAT MATERIALS OF PLANT ORIGIN ENRICHED IN INSAPONIFIABLE MATERIALS.
WO2001072265A1 (en) * 2000-03-31 2001-10-04 The Nisshin Oil Mills, Ltd. External preparation for the skin and beautifying agents
EP1213025A1 (en) * 2000-12-06 2002-06-12 Laboratoires Serobiologiques(Societe Anonyme) Cosmetic and/or dermopharmaceutical composition containing extracts obtained from the leaves of Argania spinosa
FR2857596B1 (en) * 2003-07-18 2006-02-03 Expanscience Lab USE OF A COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A LUPEOL-RICH EXTRACT AS AN ACTIVE INGREDIENT TO STIMULATE THE SYNTHESIS OF STRESS PROTEINS
ES2336570T3 (en) * 2003-10-24 2010-04-14 Cognis France, S.A.S. VEGETABLE EXTRACT AND ITS PHARMACEUTICAL AND COSMETIC USE.

Also Published As

Publication number Publication date
NZ569203A (en) 2010-08-27
BRPI0620949A2 (en) 2011-11-29
WO2007083006A2 (en) 2007-07-26
MA30035B1 (en) 2008-12-01
CN101355926A (en) 2009-01-28
NO20083307L (en) 2008-07-25
RU2428170C2 (en) 2011-09-10
WO2007083006A9 (en) 2007-10-25
UA95790C2 (en) 2011-09-12
ZA200805112B (en) 2009-03-25
IL192428A0 (en) 2009-02-11
TNSN08290A1 (en) 2009-12-29
KR20080083134A (en) 2008-09-16
FR2895677A1 (en) 2007-07-06
US20090012049A1 (en) 2009-01-08
JP2009522341A (en) 2009-06-11
AU2006336002A1 (en) 2007-07-26
EP1968536A2 (en) 2008-09-17
CA2636114A1 (en) 2007-07-26
FR2895677B1 (en) 2012-05-25
HK1124779A1 (en) 2009-07-24
CN101355926B (en) 2011-11-16
WO2007083006A3 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
RU2008132144A (en) APPLICATION OF THE UNSAPTIBLE EXTRACT OF VEGETABLE PULP FOR TREATMENT OF AGING OF SKIN
Maan et al. The therapeutic properties and applications of Aloe vera: A review
WO2013149323A1 (en) Natural products for skin care
CA3152782A1 (en) Enhanced toothpaste and kits
CN103284935A (en) Whitening and moisturizing mask and preparation method thereof
CN114929195A (en) Composition containing plant extract
CN108601762A (en) Inflammatory body activates inhibitor
JP2011162513A (en) Pomegranate seed extract, pharmaceutical composition, food and drink, and cosmetic thereof, and method for use thereof
CN103598547A (en) Lotus root starch for losing weight and reducing lipid and preparation method thereof
Olisova et al. Russian traditional medicine in dermatology
TW201642849A (en) Compositions including sesamin, methods of making and using the same in skin anti-aging and skin lightening applications
Bajpai Biological importance of Aloe vera and its active constituents
CN104116702A (en) Emblica officinalis skin-care product with effects of whitening and anti-aging
WO2013072852A4 (en) Stretch mark preventer
CN105496911A (en) Simple self-made skin-whitening facial mask
CN104013555B (en) Draft shampoo and preparation method thereof
Fale et al. A comprehensive study of herbal cosmetics prepared from flaxseed
Singh et al. Indian medicinal plants: For hair care and cosmetics
Shaikh et al. Design and evaluation of herbal lip balm by using beet root
KR20190047983A (en) A functional cosmetic composition comprising high purity melittin, Ginsenoside Rb1, Rg3 and extracts from fruits of Rosa davurica pall and preparing method thereof
Usman et al. Nutricosmetics: Role in health, nutrition, and cosmetics
CN106174583A (en) A kind of compound edible health care product of Oleum Hippophae
Ispiryan et al. Red Raspberry (Rubus idaeus L.) Seed Oil: A Review. Plants 2021, 10, 944
Warade et al. a Review on Herbal Cosmetics Used in Skin and Hair Care
CN104116649A (en) Jasminum sambac oil with whitening function and preparation technology thereof

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20161229